Dr. Negin Behazin, MD

Dr. Behazin practices at Pathway Medical Group, Inc in Garden Grove, California.

Dr. Behazin's NPI, 1497076301, was assigned on June 15, 2010. Dr. Behazin graduated from Azad University in 1997. Dr. Behazin holds California license A131359.

Dr. Behazin's primary practice is Pathway Medical Group, Inc, at 12462 Brookhurst St, Garden Grove, CA 92840 in Orange County. The practice phone is (714) 636-9850.

Dr. Behazin's primary practice is Pathway Medical Group, Inc in Garden Grove, California. The medical group on file is Pathway Medical Group. Dmand AI also links Dr. Behazin to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Behazin practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Behazin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Behazin's licenses on file in 2 states: California and Missouri.

Dmand AI lists acid reflux, atrial fibrillation and flutter, bronchitis, chronic diabetes, chronic hypertension, chronic indigestion, chronic obstructive pulmonary disease (COPD) and chronic respiratory failure among the conditions Dr. Behazin treats.

CMS data shows 172 Medicare services from Dr. Behazin across 5 procedure codes in 2024, for 62 Medicare patients. Medicare paid $14,966 for them. Every service was in an office.

CMS counts 62 Medicare patients who saw Dr. Behazin in 2024. The largest group is 65 to 74, with 33 patients. 68% of them have high blood pressure, and 60% have high cholesterol. 65% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Behazin's median patient age at 57, with 68% women.

In 2024, Dr. Behazin wrote 5,620 Medicare Part D claims for 353 patients. 88% of them were for generic drugs. CMS names the drug for 4,942 of them, across 110 drugs with 11 or more claims each, at $368,275 in total drug cost. In 2023, CMS named 4,754 claims across 110 drugs.

Dr. Behazin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Behazin, published from 2007 to 2014. 2009 was the busiest year, with 2. The most frequent topics are Lung, Respiratory Mechanics and Esophagus. Dr. Behazin has published most often in J Appl Physiol (1985). Dr. Behazin's most frequent co-authors are Atul Malhotra, MD and Aileen Z. Novero, MD.

CMS Open Payments shows 182 general payments to Dr. Behazin from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $689.

Dr. Behazin graduated from Azad University in 1997.

Dr. Behazin is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.